Development and biological evaluation of C(60) fulleropyrrolidine-thalidomide dyad as a new anti-inflammation agent. [electronic resource]
Producer: 20081205Description: 8619-26 p. digitalISSN:- 1464-3391
- Animals
- Anti-Inflammatory Agents -- chemical synthesis
- Cell Survival
- Cells, Cultured
- Extracellular Signal-Regulated MAP Kinases -- antagonists & inhibitors
- Fullerenes -- chemistry
- Lipopolysaccharides
- Macrophages -- drug effects
- Nitric Oxide -- antagonists & inhibitors
- Nitric Oxide Synthase Type II -- genetics
- Phosphorylation -- drug effects
- Pyrrolidines -- chemical synthesis
- Reactive Oxygen Species -- antagonists & inhibitors
- Thalidomide -- analogs & derivatives
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.